№ lp_2_3_12349
Year: 2026
Region / City: Washington, D.C.
Subject: Securities and Exchange
Document Type: SEC Form
Issuer: Keenova Therapeutics plc
Target Audience: Reporting Person, SEC Filers
Effective Period: 01/01/2026
Approval Date: 01/01/2026
Amendment Date: N/A
Date of Filing: 01/05/2026
Description: A document filed with the U.S. Securities and Exchange Commission detailing changes in beneficial ownership, including securities acquired, disposed of, or owned by the reporting person.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.